Tackling other infectious diseases
Gemma K. Alderton · Science · 2020
Coronavirus The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has pushed drug discovery and clinical testing to a pace previously considered impossible. In a Perspective, Gupta discusses how the structure of drug development for coronavirus disease 2019 (COVID-19) can be implemented to treat other infectious diseases that kill millions globally each year. By focusing research, implementing operational efficiencies, and ensuring large-scale financing, the author suggests that extensive drug development pipelines can be built to tackle other severe infections. Science , this issue p. [913][1] [1]: /lookup/doi/10.1126/science.abe0773